Travere Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Travere Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Travere Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -176 %, a 40.2% increase year-over-year.
  • Travere Therapeutics, Inc. annual Operating Margin for 2023 was -267 %, a 8.53% increase from 2022.
  • Travere Therapeutics, Inc. annual Operating Margin for 2022 was -292 %, a 93.2% decline from 2021.
  • Travere Therapeutics, Inc. annual Operating Margin for 2021 was -151 %, a 70.3% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -267 +24.9 +8.53% Jan 1, 2023 Dec 31, 2023
2022 -292 -141 -93.2% Jan 1, 2022 Dec 31, 2022
2021 -151 -62.4 -70.3% Jan 1, 2021 Dec 31, 2021
2020 -88.8 -10.5 -13.4% Jan 1, 2020 Dec 31, 2020
2019 -78.3 -29.6 -60.8% Jan 1, 2019 Dec 31, 2019
2018 -48.7 -14 -40.4% Jan 1, 2018 Dec 31, 2018
2017 -34.7 +8.86 +20.3% Jan 1, 2017 Dec 31, 2017
2016 -43.6 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.